GMP Certified / Propofol Injectable Emulsion 100mg/10ml

Product Details
Customization: Available
Quality Standard: Bp, USP
Ctd Dossier: Ready
Still deciding? Get samples of $ !
Request Sample
Manufacturer/Factory, Trading Company, Group Corporation
Gold Member Since 2018

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Importers and Exporters
The supplier has import and export rights
to see all verified strength labels (7)
  • GMP Certified / Propofol Injectable Emulsion 100mg/10ml
  • GMP Certified / Propofol Injectable Emulsion 100mg/10ml
  • GMP Certified / Propofol Injectable Emulsion 100mg/10ml
  • GMP Certified / Propofol Injectable Emulsion 100mg/10ml
  • GMP Certified / Propofol Injectable Emulsion 100mg/10ml
  • GMP Certified / Propofol Injectable Emulsion 100mg/10ml
Find Similar Products

Basic Info.

Model NO.
injection
Documentation
Copp, COA
Factory Certification
GMP
Transport Package
Carton
Specification
100mg/10ml
Trademark
Sinolead
Origin
China
Production Capacity
100, 000, 000 Per Year

Product Description

Product Description
Generic Name Propofol Injectable Emulsion
Strength 100mg/10ml
Packing 5 amps/box
Origin China

Value-added services:
 Packaging design by our team
 
Registration service by our team

 Registration dossier available by our team
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------


Product name:
Propofol Injectable Emulsion 100mg/10ml

Character:
This product is a white milky liquid.


Indications:
It is suitable for the induction and maintenance of general anaesthesia, as well as for enhancing sedation of supervised patients undergoing mechanical ventilation, and for performing painless abortion under anaesthesia.

Adverse reactions:
Systemic adverse reactions:
1. Induction of anesthesia is usually smooth, with little excitement. However, dose-dependent inhibition of respiratory and circulatory function was found, which was positively correlated with injection speed, and the decrease of arterial pressure and peripheral resistance was more obvious than that of sodium thiopental. During induction of anesthesia, hypotension and transient apnea may occur due to the dose, preoperative medication used, and other medications. To correct hypotension, intravenous fluids are sometimes required and the rate of propofol injection is reduced during maintenance anesthesia.
2. The incidence of muscular twin was about 1% during induction.
3. Epileptoid movement with convulsion and anisocytosis has been reported occasionally, and pulmonary edema has also been reported.
4. Anaphylaxis is rare and can be characterized by bronchospasm, erythema, and hypotension.
5. During anesthesia resuscitation, a small number of patients experienced nausea, vomiting, and headache.
6. Postoperative fever after propofol administration has been reported.
Seven. Occasional changes in urine color were reported after prolonged propofol administration.
Local adverse reactions:
Local pain may occur during propofol induction, but can be alleviated by combining lidocaine (see usage and dosage) or by using thicker veins in the forearm. Thrombosis and phlebitis are rare.

Pharmacology and toxicology:

Pharmacological action: Propofol is an intravenous general anesthetic used for the induction and maintenance of anesthesia and sedation. Usually the therapeutic dose can produce hypnotic effect about 40 seconds after intravenous injection, and the excitatory effect is small. The mechanism of action of this drug may be the activation of aminobutyric acid (GABA) receptor-chloride complex, which increases chloride ion conduction at conventional doses and desensitizes GABA receptors at large doses, thereby inhibiting the central nervous system.
Toxicological study
Genotoxicity: Propofol Ames test, Saccharomyces cerevisiae gene mutation/gene transformation test, in vitro Chinese hamster cytogenetics studies, and mouse micronucleus test results were negative.
Reproductive toxicity: Continuous intravenous administration of 15mg/kg/ day of propofol (equivalent to the clinically recommended induction dose based on body surface area) in female rats during the first two weeks of pregnancy until day 7 of gestation did not show an adverse effect on fertility. In the dominant lethal test of intravenous propofol 15mg/kg/ day for 5 consecutive days, the fertility of male rats was not affected. Propofol 15mg/kg/ day was given intravenously to rats and rabbits, and there was no harm to the fetus. However, studies have shown that propofol 15mg/kg/ day given to lactating mothers or rabbits can cause maternal death and reduce the survival rate of the young. The adverse reactions observed in the offspring may be due to the pharmacological activity of propofol on the mother (anesthetic effect).


Storage:
Store between 2-25ºC, do not freeze.
GMP Certified / Propofol Injectable Emulsion 100mg/10ml

GMP Certified / Propofol Injectable Emulsion 100mg/10ml

GMP Certified / Propofol Injectable Emulsion 100mg/10mlGMP Certified / Propofol Injectable Emulsion 100mg/10mlGMP Certified / Propofol Injectable Emulsion 100mg/10mlGMP Certified / Propofol Injectable Emulsion 100mg/10ml
 
 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier